Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 02-Dec-22 4:47 PM View:  | Bedu-Addo Frank President/CEO Director | Pds Biotechnology Corp (PDSB) | 02-Dec-22 | Option Exercise | 219,535 | $6.57 | $1,442,340.00 | 34% 646.51K to 866.05K | 9% |
| 02-Dec-22 4:47 PM View: | Bedu-Addo Frank President/CEO Director | Pds Biotechnology Corp (PDSB) | 02-Dec-22 | Payment of Exercise | 175,184 | $9.78 | $1,713,300.00 | (20%) 866.05K to 690.87K | |
| 14-Dec-21 9:10 AM View: | Hill Mathew C Chief Financial Officer | Pds Biotechnology Corp (PDSB) | 13-Dec-21 | Market Purchase | 2,900 | $8.99 | $26,060.00 | 33% 8.82K to 11.72K | < 1% |
| 14-Dec-21 9:10 AM View: | Hill Mathew C Chief Financial Officer | Pds Biotechnology Corp (PDSB) | 13-Dec-21 | Market Purchase | 200 | $9.00 | $1,800.00 | 2% 11.72K to 11.93K | < 1% |
| 21-Jun-21 4:30 PM View: | Bloomquist Delyle W | Pds Biotechnology Corp (PDSB) | 16-Jun-21 | Market Purchase | 10,000 | $9.88 | $98,778.00 | 1% 788.91K to 798.91K | |
| 21-Jun-21 4:30 PM View: | Bloomquist Delyle W | Pds Biotechnology Corp (PDSB) | 16-Jun-21 | Option Exercise | 2,970 | $5.99 | $17,790.30 | < 1% 785.94K to 788.91K | |
| 17-Jun-21 6:45 PM View: | Freitag Gregory Gene Director | Pds Biotechnology Corp (PDSB) | 15-Jun-21 | Private Purchase | 5,882 | $8.50 | $49,997.00 | 15% 40.27K to 46.15K | |
| 17-Jun-21 7:15 PM View: | Glover Steve C Director | Pds Biotechnology Corp (PDSB) | 15-Jun-21 | Private Purchase | 5,882 | $8.50 | $49,997.00 | 10% 57.91K to 63.79K | |
| 17-Jun-21 7:26 PM View: | Bedu-Addo Frank President/CEO Director | Pds Biotechnology Corp (PDSB) | 15-Jun-21 | Payment of Exercise | 27,166 | $12.86 | $349,355.00 | (4%) 673.68K to 646.51K | |
| 17-Jun-21 7:26 PM View: | Bedu-Addo Frank President/CEO Director | Pds Biotechnology Corp (PDSB) | 15-Jun-21 | Option Exercise | 53,174 | $6.57 | $349,353.00 | 9% 620.51K to 673.68K | |
| 17-Jun-21 6:52 PM View: | van Voorhees Seth Chief Financial Officer | Pds Biotechnology Corp (PDSB) | 15-Jun-21 | Private Purchase | 17,647 | $8.50 | $150,000.00 | 100% 0 to 17.65K | |
| 17-Jun-21 7:09 PM View: | Ali-Jackson Kamil Director | Pds Biotechnology Corp (PDSB) | 15-Jun-21 | Private Purchase | 11,764 | $8.50 | $99,994.00 | 100% 0 to 11.76K | |
| 19-Feb-20 4:30 PM View: | Sykes Richard Director | Pds Biotechnology Corp (PDSB) | 14-Feb-20 | Grant | 384,615 | $1.30 | $499,999.00 | 636% 60.49K to 445.11K | 79% |
| 19-Feb-20 4:30 PM View: | Saik Andrew Chief Financial Officer Director | Pds Biotechnology Corp (PDSB) | 14-Feb-20 | Grant | 38,400 | $1.30 | $49,920.00 | 926% 4.15K to 42.55K | 79% |
| 19-Feb-20 4:31 PM View: | Freitag Gregory Gene Director | Pds Biotechnology Corp (PDSB) | 14-Feb-20 | Grant | 38,400 | $1.30 | $49,920.00 | 2052% 1.87K to 40.27K | 79% |
| 19-Feb-20 4:30 PM View: | Glover Steve C Director | Pds Biotechnology Corp (PDSB) | 14-Feb-20 | Grant | 38,400 | $1.30 | $49,920.00 | 197% 19.51K to 57.91K | 79% |
| 18-Mar-19 5:38 PM View: | Blech Isaac Director | Pds Biotechnology Corp (PDSB) | 15-Mar-19 | Option Exercise | 10,000 | -- | -- | 100% 0 to 10.0K | |
| 18-Mar-19 5:52 PM View: | Ratcliffe Liam Director | Pds Biotechnology Corp (PDSB) | 15-Mar-19 | Option Exercise | 10,000 | -- | -- | < 1% 2.34M to 2.35M | |
| 18-Mar-19 5:59 PM View: | MacDonald R. Loch Director | Pds Biotechnology Corp (PDSB) | 15-Mar-19 | Option Exercise | 10,000 | -- | -- | 2% 577.73K to 587.73K | |
| 18-Mar-19 5:42 PM View: | Blech Isaac Director | Pds Biotechnology Corp (PDSB) | 15-Mar-19 | Option Exercise | 10,000 | -- | -- | 100% 0 to 10.0K | |
| 18-Mar-19 5:47 PM View: | Loughlin James J Director | Pds Biotechnology Corp (PDSB) | 15-Mar-19 | Option Exercise | 10,000 | -- | -- | 39% 25.63K to 35.63K | |
| 18-Mar-19 5:57 PM View: | Spiegel Robert J. Director | Pds Biotechnology Corp (PDSB) | 15-Mar-19 | Option Exercise | 10,000 | -- | -- | 26% 38.66K to 48.66K | |
| 18-Mar-19 5:33 PM View: | Barer Sol J Director | Pds Biotechnology Corp (PDSB) | 15-Mar-19 | Option Exercise | 20,000 | -- | -- | 3% 658.08K to 678.08K | |
| 18-Mar-19 5:36 PM View: | Crane Rosemary A Director | Pds Biotechnology Corp (PDSB) | 15-Mar-19 | Option Exercise | 10,000 | -- | -- | 100% 0 to 10.0K | |
| 18-Mar-19 5:50 PM View: | Middlekauff W Bradford Senior VP, GC and Secretary | Pds Biotechnology Corp (PDSB) | 15-Mar-19 | Option Exercise | 49,766 | -- | -- | 207% 24.0K to 73.77K | |
| 18-Mar-19 5:44 PM View: | Leuthner Brian A President and CEO Director | Pds Biotechnology Corp (PDSB) | 15-Mar-19 | Option Exercise | 169,032 | -- | -- | 36% 464.35K to 633.38K | |
| 18-Mar-19 5:55 PM View: | Saik Andrew Chief Financial Officer | Pds Biotechnology Corp (PDSB) | 15-Mar-19 | Option Exercise | 82,999 | -- | -- | 100% 0 to 83.0K | |
| 30-Mar-18 7:19 PM View: | Conti Kurt G Director | Pds Biotechnology Corp (PDSB) | 23-Mar-18 | Disposition (other) | 58,476 | -- | -- | (5%) 1.17M to 1.11M | |
| 22-Mar-18 4:03 PM View: | MacDonald R. Loch Chief Scientific Officer Director | Pds Biotechnology Corp (PDSB) | 22-Mar-18 | Market Sale (Planned) | 2,500 | $16.41 | $41,025.00 | (< 1%) 573.1K to 570.6K | 99% |
| 21-Mar-18 11:34 AM View: | MacDonald R. Loch Chief Scientific Officer Director | Pds Biotechnology Corp (PDSB) | 21-Mar-18 | Market Sale (Planned) | 2,500 | $16.52 | $41,300.00 | (< 1%) 575.6K to 573.1K | 99% |
| 21-Mar-18 11:34 AM View: | MacDonald R. Loch Chief Scientific Officer Director | Pds Biotechnology Corp (PDSB) | 20-Mar-18 | Market Sale (Planned) | 5,000 | $16.47 | $82,350.00 | (< 1%) 580.6K to 575.6K | 99% |
| 21-Mar-18 11:34 AM View: | MacDonald R. Loch Chief Scientific Officer Director | Pds Biotechnology Corp (PDSB) | 19-Mar-18 | Market Sale (Planned) | 2,500 | $16.66 | $41,650.00 | (< 1%) 583.1K to 580.6K | 99% |
| 05-Mar-18 8:19 AM View: | Leuthner Brian A President and CEO Director | Pds Biotechnology Corp (PDSB) | 02-Mar-18 | Market Sale (Planned) | 2,500 | $15.08 | $37,700.00 | (< 1%) 458.36K to 455.86K | 99% |
| 05-Mar-18 8:19 AM View: | Leuthner Brian A President and CEO Director | Pds Biotechnology Corp (PDSB) | 01-Mar-18 | Market Sale (Planned) | 2,500 | $14.81 | $37,025.00 | (< 1%) 460.86K to 458.36K | 99% |
| 23-Feb-18 5:28 PM View: | Leuthner Brian A President and CEO Director | Pds Biotechnology Corp (PDSB) | 23-Feb-18 | Market Sale (Planned) | 2,500 | $15.37 | $38,425.00 | (< 1%) 463.36K to 460.86K | 99% |
| 22-Feb-18 5:00 PM View: | MacDonald R. Loch Chief Scientific Officer Director | Pds Biotechnology Corp (PDSB) | 22-Feb-18 | Market Sale (Planned) | 2,500 | $14.49 | $36,225.00 | (< 1%) 585.6K to 583.1K | 99% |
| 23-Feb-18 5:28 PM View: | Leuthner Brian A President and CEO Director | Pds Biotechnology Corp (PDSB) | 22-Feb-18 | Market Sale (Planned) | 2,500 | $15.47 | $38,675.00 | (< 1%) 465.86K to 463.36K | 99% |
| 22-Feb-18 5:00 PM View: | MacDonald R. Loch Chief Scientific Officer Director | Pds Biotechnology Corp (PDSB) | 21-Feb-18 | Market Sale (Planned) | 5,000 | $13.82 | $69,100.00 | (< 1%) 590.6K to 585.6K | 99% |
| 22-Feb-18 5:00 PM View: | MacDonald R. Loch Chief Scientific Officer Director | Pds Biotechnology Corp (PDSB) | 20-Feb-18 | Market Sale (Planned) | 5,000 | $13.75 | $68,750.00 | (< 1%) 595.6K to 590.6K | 99% |
| 02-Feb-18 9:15 PM View: | Leuthner Brian A President and CEO Director | Pds Biotechnology Corp (PDSB) | 02-Feb-18 | Market Sale (Planned) | 2,500 | $12.96 | $32,400.00 | (< 1%) 468.36K to 465.86K | 99% |
| 02-Feb-18 9:15 PM View: | Leuthner Brian A President and CEO Director | Pds Biotechnology Corp (PDSB) | 01-Feb-18 | Market Sale (Planned) | 2,500 | $13.14 | $32,850.00 | (< 1%) 470.86K to 468.36K | 99% |
| 03-Jan-18 6:48 PM View: | Leuthner Brian A President and CEO Director | Pds Biotechnology Corp (PDSB) | 03-Jan-18 | Market Sale (Planned) | 2,500 | $10.11 | $25,275.00 | (< 1%) 473.36K to 470.86K | 99% |
| 03-Jan-18 6:48 PM View: | Leuthner Brian A President and CEO Director | Pds Biotechnology Corp (PDSB) | 02-Jan-18 | Market Sale (Planned) | 2,500 | $10.11 | $25,275.00 | (< 1%) 475.86K to 473.36K | 99% |
| 05-Dec-17 5:39 PM View: | Leuthner Brian A President and CEO Director | Pds Biotechnology Corp (PDSB) | 05-Dec-17 | Market Sale (Planned) | 2,500 | $9.68 | $24,200.00 | (< 1%) 478.36K to 475.86K | 99% |
| 05-Dec-17 5:39 PM View: | Leuthner Brian A President and CEO Director | Pds Biotechnology Corp (PDSB) | 04-Dec-17 | Market Sale (Planned) | 2,500 | $9.97 | $24,925.00 | (< 1%) 480.86K to 478.36K | 99% |
| 05-Dec-17 5:39 PM View: | Leuthner Brian A President and CEO Director | Pds Biotechnology Corp (PDSB) | 01-Dec-17 | Market Sale (Planned) | 2,500 | $9.92 | $24,800.00 | (< 1%) 483.36K to 480.86K | 99% |
| 22-Nov-17 3:08 PM View: | Marchio Albert N II Chief Accounting & Adm Officer | Pds Biotechnology Corp (PDSB) | 22-Nov-17 | Market Sale | 3,361 | $10.00 | $33,610.00 | (100%) 3.36K to 0 | 99% |
| 03-Nov-17 5:53 PM View: | Leuthner Brian A President and CEO Director | Pds Biotechnology Corp (PDSB) | 03-Nov-17 | Market Sale (Planned) | 2,500 | $10.86 | $27,150.00 | (< 1%) 485.86K to 483.36K | 99% |
| 03-Nov-17 5:53 PM View: | Leuthner Brian A President and CEO Director | Pds Biotechnology Corp (PDSB) | 02-Nov-17 | Market Sale (Planned) | 2,500 | $10.94 | $27,350.00 | (< 1%) 488.36K to 485.86K | 99% |
| 03-Nov-17 5:53 PM View: | Leuthner Brian A President and CEO Director | Pds Biotechnology Corp (PDSB) | 01-Nov-17 | Market Sale (Planned) | 2,500 | $10.92 | $27,300.00 | (< 1%) 490.86K to 488.36K | 99% |
